Key Financial Data Of Group

Cyfuse Biomedical K.K. - Filing #7567836

Concept 2023-01-01 to
2023-03-31
As at
2023-03-31
As at
2022-12-31
2022-01-01 to
2022-12-31
Key financial data of group
Business results of group
Net sales
7,070,000 JPY
374,477,000 JPY
Ordinary profit (loss)
-167,047,000 JPY
-433,165,000 JPY
Net assets
3,605,531,000 JPY
3,769,801,000 JPY
Total assets
4,594,521,000 JPY
4,815,337,000 JPY
Basic earnings (loss) per share
-21.56
-177.67
Diluted earnings per share
Equity-to-asset ratio
0.785 xbrli:pure
0.783 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.